Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: Britain and the EU also agreed to cancel face-to-face trade negotiations planned for next week in London due to the outbreak. At a meeting of the government's emergency committee on Thursday, Johnson moved Britain's response to the outbreak to the so-called "delay phase", aimed at putting off the peak until the summer months, ending a phase of outright containment. "It's going to spread further," Johnson said at a news conference, flanked by the government's top scientific and medical advisers. "I must level with you, level with the British public - more families, many more families are going to lose loved ones before their time." Rapidly spreading disruptions to business, trade and everyday life around the world have triggered panic on global markets, including in Britain. Britain's FTSE 100 was down 10.9%, its worst one-day performance since 1987. Sterling fell three cents against the dollar, the biggest fall since the 2016 vote to leave the EU. The British government has faced questions over why it is not taking the more far-reaching measures seen in many other countries. Johnson defended his approach, saying the government was following scientific advice and would "do the right thing at the right time". He said those showing even mild symptoms of having the virus should self-isolate for at least seven days. In the next few weeks that advice would change to entire households being asked to stay at home if one person has symptoms. "This is the worst public health crisis for a generation," he said. The number of confirmed cases of coronavirus across the United Kingdom rose 29% percent to 590 over the past 24 hours. Ten people with coronavirus have died in the UK. Graphic: UK coronavirus cases - here "There are currently about 590 cases identified in the UK and there are more than 20 patients on intensive care units," chief scientific adviser Patrick Vallance said. "If you calculate what that really means in terms of the total number, it is much more likely that you have somewhere between 5,000 and 10,000 people infected at the moment." Vallance said Britain was currently on a trajectory about four weeks behind Italy, which has reported more than 15,000 cases and 1,000 deaths. He predicted the peak of coronavirus cases in Britain may be at least 10 to 14 weeks away. England's chief medical adviser Chris Whitty said not all suspected cases of the virus would be formally tested, with the government focusing on those in hospital. The British plan for dealing with the outbreak has three main phases - containment, delay and mitigation. The delay phase includes consideration of so-called social distancing measures such as more home-working, reducing large scale gatherings and closing schools. Johnson said Britain was not cancelling major public events and schools would stay open for now but that advice could change as the virus spreads. Whitty said at some point social interaction for old and vulnerable people would need to be reduced, but not yet. "People start off with the best of intentions but enthusiasm at a certain point starts to flag," Whitty said. "So we do need to do it at the last point it is reasonable ... to get through what will be quite difficult things to do." Meanwhile, Ireland is to shut schools, universities and childcare facilities until March 29 and restrict mass gatherings, acting Prime Minister Leo Varadkar said.

A: PM Johnson warns Britons: more loved ones are going to die from coronavirus.
****
Q: "Like its competitors, the Times did not discuss costsanomissionwhich perhaps is more acceptable in this story since it clearly indicated that this is not very close to being a marketable product. Nevertheless, we would have liked to have seen some mention of the financial impact. Many patients with type 1 diabetes are not using currently available pumps and sensors because of the high cost of these devices. It seems likely that this new treatment, if it ever becomes widely available, will be as expensive or more so than the current pump and sensor technology. We applaud the Times for avoiding the term ""artificial pancreas"" in the headline and using it sparingly in the body of the story. The competing stories couldn't resist it. We can understand whymarketers and media relations people would favor this term because of its promotional value, but we don't think it's agood way to describe this technology in an objective piece of journalism. ""Artificial pancreas"" is misleading because we're not really anywhere close tobeing able to replicate what the normal human pancreasdoes through artificial technology. Forgetting for a momentthat the pancreas does much morethan simply dispense insulin (it alsoproduces a number of other hormones anddigestive enzymes that aren't impacted by diabetes),what's more important is how the pancreas worksin concert withthe brain and other systems to regulateglucose in a very tight range. The normal human pancreas starts releasinginsulin beforewe eat in response to complex environmental cues, whereas any artificial system would need tobe told thatmeal is coming or react to therise in glucose after thefact. Plus,insulinproduced by the bodystarts acting rightaway, whereas insulin analogues take about 20 minutes to takeeffect. Put this all together and we see that the ""artificial pancreas"" will, for the foreseeable future, require human intervention to predictpost-mealinsulin needs and dosing or else patients will be at risk of post-meal blood sugar spikes. And it's not at all clear that such a systemwill improve overall bloodsugar management compared with existing methods. The term""artificial pancreas"" conjures up a vision of totally automated glucose management and essentially a ""cure"" for type 1 diabetes. This isoverselling what the technology can do. The Times waited until the last 3 paragraphs of an 1,100-word story to hintthat an automated system could deliver unsafe doses of insulin. It isn't until the last sentence thatwe learn that the system would need to be ""exquisitely reliable"" in order to be safe. We feel the story should have raised these issues earlier and that it could have done more to emphasize just how difficult itwill befor any device to calculate insulin requirements on the fly. Insulin dosingis affected byfactorsranging from how much aperson has exercised to whatand how much they have eaten. It's conceivable that technology can account for all of these variables,but there are a lot ways thingscould go wrong, with potentially deadly results. It's a close call, butwe don't feel thestorydid enough to call attention to these issues. In contrast to its competitors, which allled readersto believe there had been a fully automated system sensing glucose levels and dispensing insulin to the participants in this study, the Times noted thatthe insulin was dispensed by a nurse based oncalculations made by a computer algorithm. The Times clearly indicated that the significance of this test was as a ""proof of concept"" that the algorithm works and is safe, not as a test of any specific device. It noted that a fully automated system combining glucosemonitoring and insulin delivery was still ""hypothetical."" In addition,the Times story wasthe only one to draw attention to the small size of this study and the fact the findings were not statistically significant for the primary outcomes. This noteofcaution was completely lacking from the competingcoverage. The story did not exaggerate the effects of type 1 diabetes. The story includes quotesfrom interviews with one of the study investigators and another researcher, and identifies both as having ties to diabetes products manufacturers. It also quotes an analyst at an investment firm. It would have been better had theyincluded one more source who didn't have commercial ties to specific products. The story describes currently available technology for glucose monitoring and insulin infusion. It describes the limitations of current approaches for managing insulin, especially during the overnight period. The story is a bit misleading in that it leaves the impression that all type 1 diabetics are currently using pumps at night. This is not actually the case. Most people are doing self monitoring of blood glucose and making judgement calls on whether and how much insulin to administer. However, the story does enough for a satisfactory in our view. The Times did a good job of describing the system used in this study and how close it is to being commercially available. It called the system ""experimental""and said that it was ""notfully automated."" It said that a fullyautomated glucose monitor/insulindelivery system was still ""hypothetical"" and would face regulatory hurdles before it could be marketed to the public. The story describes the progression from skin prick glucose testing to continuous monitoring and insulin pumps. It places the new developments in this field on this continuum. There could have beenmore discussion of many of the recent advances that have made daytime hyper- and hypoglycemia less of a problem such asthe newer short-acting insulins. The story did not rely on any news release."

A: Insulin Study Could Lead to New Dosage Devices
****
Q: The Korea Centers of Disease Control and Prevention said Wednesday that the woman, who was diagnosed with pneumonia on Tuesday following two business trips to China last month, represented the country's first possible case of the respiratory illness whose cause remains unknown. The unidentified woman, who works for a South Korean company near capital Seoul, has experienced cough and fever since returning from a five-day trip to the Chinese city of Xiamen on Dec. 30, the KCDC said in a press release. She had also visited Wuhan, the mainland Chinese city where the outbreak originated, for five days in mid-December. She told South Korean doctors she made no contact with animals while she was there and didn't visit a seafood market in Wuhan's suburbs where most of the cases have been traced to. The KCDC said the woman was in relatively good condition and undergoing tests at a hospital south of Seoul to confirm whether she has the same illness as the Wuhan patients. South Korean officials have tightened monitoring of people entering from China and advised travelers to avoid contact with animals and take extra care in personal hygiene. The disease an unidentified form of viral pneumonia has sent 59 people to the hospital in Wuhan in central Hubei province. As of Sunday, seven were in critical condition, while the rest were stable. In Hong Kong, a total of 15 patients were being treated Sunday for symptoms including fever and respiratory infection after recent visits to Wuhan. It is not clear whether they have the same illness as the Wuhan patients.

A:
South Korea reports 1st possible case of viral pneumonia.
****